Shanghai Haohai Biological Tech Co Asset Resilience Ratio

Latest as of September 2025: 1.51%

Shanghai Haohai Biological Tech Co asset resilience ratio. Shanghai Haohai Biological Tech Co (688366) has an Asset Resilience Ratio of 1.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Haohai Biological Tech Co defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥107.18 Million
≈ $15.68 Million USD Cash + Short-term Investments

Total Assets

CN¥7.12 Billion
≈ $1.04 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shanghai Haohai Biological Tech Co (2012–2024)

Asset resilience ratio of Shanghai Haohai Biological Tech Co from 2012 to 2024. This chart shows how Shanghai Haohai Biological Tech Co's Asset Resilience Ratio has changed over time. Read debt load of Shanghai Haohai Biological Tech Co for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Haohai Biological Tech Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Haohai Biological Tech Co (688366) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥107.18 Million 1.51%
Total Liquid Assets CN¥107.18 Million 1.51%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Haohai Biological Tech Co maintains only 1.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Haohai Biological Tech Co Industry Peers by Asset Resilience Ratio

Compare Shanghai Haohai Biological Tech Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
argenx NV ADR
NASDAQ:ARGX
Biotechnology 15.95%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Summit Therapeutics PLC
NASDAQ:SMMT
Biotechnology 36.07%
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Verona Pharma PLC ADR
NASDAQ:VRNA
Biotechnology 0.00%
3SBio Inc
F:83B
Biotechnology 10.64%

Shanghai Haohai Biological Tech Co Asset Resilience Ratio by Year (2012–2024)

Shanghai Haohai Biological Tech Co asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Haohai Biological Tech Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.23% CN¥87.85 Million
≈ $12.85 Million
CN¥7.12 Billion
≈ $1.04 Billion
+1.07pp
2023-12-31 0.17% CN¥11.76 Million
≈ $1.72 Million
CN¥7.11 Billion
≈ $1.04 Billion
+0.07pp
2022-12-31 0.10% CN¥6.75 Million
≈ $987.58K
CN¥6.89 Billion
≈ $1.01 Billion
+0.01pp
2021-12-31 0.09% CN¥6.38 Million
≈ $933.01K
CN¥6.95 Billion
≈ $1.02 Billion
-0.15pp
2020-12-31 0.24% CN¥15.14 Million
≈ $2.22 Million
CN¥6.30 Billion
≈ $921.70 Million
-1.59pp
2018-12-31 1.83% CN¥81.28 Million
≈ $11.89 Million
CN¥4.44 Billion
≈ $649.18 Million
+0.69pp
2013-12-31 1.14% CN¥7.09 Million
≈ $1.04 Million
CN¥621.18 Million
≈ $90.90 Million
-0.42pp
2012-12-31 1.56% CN¥7.00 Million
≈ $1.02 Million
CN¥448.04 Million
≈ $65.56 Million
--
pp = percentage points

About Shanghai Haohai Biological Tech Co

SHG:688366 China Biotechnology
Market Cap
$834.98 Million
CN¥5.71 Billion CNY
Market Cap Rank
#9370 Global
#2325 in China
Share Price
CN¥30.00
Change (1 day)
-0.76%
52-Week Range
CN¥28.61 - CN¥52.20
All Time High
CN¥268.82
About

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more